Home Healthcare Pharmaceuticals End-Stage Renal Disease Market

End-Stage Renal Disease Market Size, Share & Trends Analysis Report By Treatment (Transplant, Dialysis), By Diagnosis (Blood Test, Urine Test, Imaging Test, Others), By End-User (Hospitals and Clinics, Dialysis Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. End-Stage Renal Disease Market, By Treatment 2022-2034 (USD MILLION/ Units)
    1. Transplant
    2. Dialysis
  2. End-Stage Renal Disease Market, By Diagnosis 2022-2034 (USD MILLION/ Units)
    1. Blood Test
    2. Urine Test
    3. Imaging Test
    4. Others
  3. End-Stage Renal Disease Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Dialysis Centers
    3. Others
  4. Regional End-Stage Renal Disease Market
    1. North America
      1. North America End-Stage Renal Disease Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Transplant
        2. Dialysis
      2. North America End-Stage Renal Disease Market By Diagnosis 2022-2034 (USD MILLION/ Units)
        1. Blood Test
        2. Urine Test
        3. Imaging Test
        4. Others
      3. North America End-Stage Renal Disease Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dialysis Centers
        3. Others
      4. U.S.
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      5. Canada
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
    2. Europe
      1. Europe End-Stage Renal Disease Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Transplant
        2. Dialysis
      2. Europe End-Stage Renal Disease Market By Diagnosis 2022-2034 (USD MILLION/ Units)
        1. Blood Test
        2. Urine Test
        3. Imaging Test
        4. Others
      3. Europe End-Stage Renal Disease Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dialysis Centers
        3. Others
      4. U.K.
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      5. Germany
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      6. France
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      7. Spain
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      8. Italy
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      9. Russia
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      10. Nordic
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      11. Benelux
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      12. Rest of Europe
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
    3. APAC
      1. APAC End-Stage Renal Disease Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Transplant
        2. Dialysis
      2. APAC End-Stage Renal Disease Market By Diagnosis 2022-2034 (USD MILLION/ Units)
        1. Blood Test
        2. Urine Test
        3. Imaging Test
        4. Others
      3. APAC End-Stage Renal Disease Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dialysis Centers
        3. Others
      4. China
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      5. Korea
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      6. Japan
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      7. India
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      8. Australia
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      9. Singapore
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      10. Taiwan
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      11. South East Asia
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      12. Rest of Asia-Pacific
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
    4. Middle East and Africa
      1. Middle East and Africa End-Stage Renal Disease Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Transplant
        2. Dialysis
      2. Middle East and Africa End-Stage Renal Disease Market By Diagnosis 2022-2034 (USD MILLION/ Units)
        1. Blood Test
        2. Urine Test
        3. Imaging Test
        4. Others
      3. Middle East and Africa End-Stage Renal Disease Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dialysis Centers
        3. Others
      4. UAE
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      5. Turkey
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      6. Saudi Arabia
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      7. South Africa
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      8. Egypt
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      9. Nigeria
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      10. Rest of MEA
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
    5. LATAM
      1. LATAM End-Stage Renal Disease Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Transplant
        2. Dialysis
      2. LATAM End-Stage Renal Disease Market By Diagnosis 2022-2034 (USD MILLION/ Units)
        1. Blood Test
        2. Urine Test
        3. Imaging Test
        4. Others
      3. LATAM End-Stage Renal Disease Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dialysis Centers
        3. Others
      4. Brazil
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      5. Mexico
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      6. Argentina
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      7. Chile
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      8. Colombia
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
      9. Rest of LATAM
        1. Transplant
        2. Dialysis
        3. Blood Test
        4. Urine Test
        5. Imaging Test
        6. Others
        7. Hospitals and Clinics
        8. Dialysis Centers
        9. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.